These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Diabetes mellitus and cardiovascular disease. Pandora's box has been opened. Berry J; Keebler ME; McGuire DK Herz; 2004 Aug; 29(5):456-62. PubMed ID: 15340730 [TBL] [Abstract][Full Text] [Related]
31. Possible mechanisms of direct cardiovascular impact of GLP-1 agonists and DPP4 inhibitors. Bistola V; Lambadiari V; Dimitriadis G; Ioannidis I; Makrilakis K; Tentolouris N; Tsapas A; Parissis J Heart Fail Rev; 2018 May; 23(3):377-388. PubMed ID: 29383638 [TBL] [Abstract][Full Text] [Related]
32. Medical management of diabetic retinopathy: an overview. Malek M; Khamseh ME; Aghili R; Emami Z; Najafi L; Baradaran HR Arch Iran Med; 2012 Oct; 15(10):635-40. PubMed ID: 23020540 [TBL] [Abstract][Full Text] [Related]
33. Vitamin D and Type 2 Diabetes Mellitus. Issa CM Adv Exp Med Biol; 2017; 996():193-205. PubMed ID: 29124701 [TBL] [Abstract][Full Text] [Related]
34. Prevention of cardiovascular complications of diabetes mellitus by aspirin. Nobles-James C; James EA; Sowers JR Cardiovasc Drug Rev; 2004; 22(3):215-26. PubMed ID: 15492769 [TBL] [Abstract][Full Text] [Related]
35. Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland. Tuomilehto J; Borch-Johnsen K; Molarius A; Forsén T; Rastenyte D; Sarti C; Reunanen A Diabetologia; 1998 Jul; 41(7):784-90. PubMed ID: 9686919 [TBL] [Abstract][Full Text] [Related]
36. A pilot study using flash continuous glucose monitoring in patients with type-2 diabetes on multiple anti-diabetic agents during Ramadan. Bashir M; Elhadd T; Ali H; Baagar K; Abdel Hakam IA; Al-Mohanadi DHS; Naem E; Al Abdulla A; Mohammed K; Abou-Samra AB Diabetes Metab Syndr; 2018 Nov; 12(6):965-968. PubMed ID: 29895446 [TBL] [Abstract][Full Text] [Related]
37. Cardiovascular disease prevention in patients with type 2 diabetes: The role of oral anti-diabetic agents. Ajjan RA; Grant PJ Diab Vasc Dis Res; 2006 Dec; 3(3):147-58. PubMed ID: 17160909 [TBL] [Abstract][Full Text] [Related]
38. Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus. Yandrapalli S; Jolly G; Horblitt A; Sanaani A; Aronow WS Postgrad Med; 2017 Nov; 129(8):811-821. PubMed ID: 28749197 [TBL] [Abstract][Full Text] [Related]
39. Perioperative cardiovascular risk stratification of patients with diabetes who undergo elective major vascular surgery. Axelrod DA; Upchurch GR; DeMonner S; Stanley JC; Khuri S; Daley J; Henderson WG; Hayward R J Vasc Surg; 2002 May; 35(5):894-901. PubMed ID: 12021704 [TBL] [Abstract][Full Text] [Related]
40. Anti-diabetic medications: How to make a choice? Babiker A; Al Dubayee M Sudan J Paediatr; 2017; 17(2):11-20. PubMed ID: 29545660 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]